PNU 282987 is a selective alpha7 nicotinic acetylcholine receptor (nAChR) agonist (Ki = 26 nM).1 The alpha7 nAChR is a potential therapeutic target of cognitive deficits in diseases such as Alzheimers, Parkinsons, schizophrenia, and attention deficit disorders -
* VAT and and shipping costs not included. Errors and price changes excepted